about
Ovarian cancer-related hypophosphatemic osteomalacia--a case report.Evaluation of bladder diary parameters based on correlation with the volume at strong desire to void in filling cystometryTriage of Atypical Glandular Cell by SOX1 and POU4F3 Methylation: A Taiwanese Gynecologic Oncology Group (TGOG) StudyUp-regulation of C1GALT1 promotes breast cancer cell growth through MUC1-C signaling pathwayClinical Outcomes and Urodynamic Effects of Tailored Transvaginal Mesh Surgery for Pelvic Organ Prolapse.Brain metastases from early stage endometrial carcinoma 8 years after primary treatment: case report and review of the literature.Comparison of recurrence rates after anterior colporrhaphy for cystocele using three different surgical techniques.Spontaneous rupture of an ovarian artery aneurysm: case report and review of the literature.Utilizing preoperative 20-minute pad testing with vaginal gauze packing for indicating concomitant midurethral sling during cystocele repair.C1GALT1 Seems to Promote In Vitro Disease Progression in Ovarian Cancer.Clinical and urodynamic effects of baclofen in women with functional bladder outlet obstruction: Preliminary report.Mucin glycosylating enzyme GALNT2 regulates the malignant character of hepatocellular carcinoma by modifying the EGF receptor.Non HPV-related cervical squamous cell carcinoma with unusual histologic characteristics mimicking a giant immature condyloma: a case report.Factors associated with fecal incontinence in women with lower urinary tract symptoms.Sequential comparisons of postoperative urodynamic changes between retropubic and transobturator midurethral tape procedures.Frequent nocturia episodes, a suboptimal response to treatment, and small bladder capacity predict the need for persistent antimuscarinic therapy or re-treatment after discontinuation of antimuscarinics in female overactive bladder.Comparisons of the Clinical Outcomes and Urodynamic Effects of Mirabegron versus Tolterodine Treatment for Female Overactive Bladder Syndrome: A Subgroup Analysis of a Controlled, Randomised, Prospective Study.Psychometric assessment of female overactive bladder syndrome and antimuscarinics-related effects.Primary surgery versus primary radiation therapy for FIGO stages I-II small cell carcinoma of the uterine cervix: A retrospective Taiwanese Gynecologic Oncology Group study.Autonomic dysfunction and arterial stiffness in female overactive bladder patients and antimuscarinics related effects.Subserosal pyomyoma in a virgin female: sonographic and computed tomographic imaging features.Urodynamic and Bladder Diary Factors Predict Overactive Bladder-wet in Women: A Comparison With Overactive Bladder-dryEarly-stage ovarian carcinoma combined with pulmonary tuberculosis mimicking advanced ovarian cancer: a case reportOverexpression of cyclin D1 and c-Myc gene products in human primary epithelial ovarian cancerInserting the tunneller during an outside-in transobturator tape procedure by syringe-needle guidanceTransvaginal cystocele repair using pursestring technique reinforced with custom-tailored two-armed meshComparison of clinical outcomes between tailored transvaginal mesh surgery and native tissue repair for pelvic organ prolapseRisk factors for coexistence of cervical elongation in uterine prolapseComparison of the vault prolapse rate after vaginal hysterectomy with or without residual uterine ligament ligations: A retrospective cohort studyPrimary ovarian mucinous carcinoid tumor: A case report and review of literature
P50
Q34628431-6C0CCF89-5172-4FD2-B72D-A537A003A6F0Q34904965-A117516E-BFD2-463A-85AA-7F4BED85E3ADQ35658404-9AF6C5C8-389B-4D4B-8063-8F1C258D9E06Q35742481-80306745-B54A-4019-9819-907164EC71FAQ36304524-D07F768F-63AD-4A51-BBA8-FBB42A74A400Q36525885-2A9C92C1-EAAF-4872-A640-C409B7BB777FQ36688266-A7D0F2DC-9639-44F1-8DD1-ED979E0B54B5Q37499808-7C3D3F17-61EF-479C-BE79-0B0F0CBBC635Q38158802-87409016-8D6B-4379-9B4B-7825980E90A4Q38789533-04CE7AFA-4E3C-42B2-883C-DC4D74AC57BDQ38816006-495AF2B5-54AF-45EF-9DA9-8B3705952E6EQ39459644-047472C9-262B-4D37-BDF3-4D1E50120722Q43545915-3D6F87D8-98AF-45D9-B78C-9FCEE3288501Q46794583-6CBC0D44-7F06-4B46-A68C-C8DF7F877335Q47605594-B6F66261-5B17-4CF1-97C3-90922E66C13FQ47682643-58B2D7E4-FEE4-4701-986C-238F1EF9715EQ47784907-BDC3E535-989F-4D83-A7F9-1828ECB26569Q48065044-E7F2B342-1F3F-46BF-8383-67273DE0ACF5Q48091516-06873A48-F7B4-4229-AFE1-D866BFBC9B67Q51127982-C8BF7FC9-A79B-4C80-90FF-C252E637B346Q51513157-803CC181-722C-4A87-AE71-A91FA732276AQ64098965-72C09E6E-D299-4932-A500-B05BC5F7E41DQ80550853-27307645-72AC-4E30-B18D-4977FC4ABF61Q81240096-C8F2EB85-7312-455D-AFBF-0EB01F107728Q84715399-F554BD0C-5F04-4A1C-8185-6A3F05E31707Q84930949-4BCAC432-E195-40D9-8F0B-C49D1915373CQ90201577-6C73B633-31D6-4050-B7D7-58FE0765E22CQ91139098-1D8ED778-4E18-4FFA-81EA-297ED9CC5007Q91780913-DF3C062A-BFB7-4726-BBC1-AE58454B313BQ91897759-1CBF9D17-AE4C-431C-AB22-E87CB830F8AD
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Chi-Hau Chen
@ast
Chi-Hau Chen
@en
Chi-Hau Chen
@es
Chi-Hau Chen
@nl
type
label
Chi-Hau Chen
@ast
Chi-Hau Chen
@en
Chi-Hau Chen
@es
Chi-Hau Chen
@nl
prefLabel
Chi-Hau Chen
@ast
Chi-Hau Chen
@en
Chi-Hau Chen
@es
Chi-Hau Chen
@nl
P1153
P106
P1153
35331748700
56248357600
56571679700
P31
P496
0000-0003-4903-7878